Support of existing Low Density Lipid (LDL) Removal Apheresis Systems
NHS Blood and Transplant · Awarded
- Buyer
- NHS Blood and Transplant
- Status
- Awarded
- Country
- United Kingdom
- Region
- EU - Western Europe
- Sector
- Manufacturing
- Reference
- UK-CFA-ocds-b5fd17-d70af731-d753-40ab-87b9-bea99abb9331
- Published
- 2026-02-18
- Deadline
- 2025-08-31
Tender summary
NHS Blood and Transplant (NHBST) is a Special Health Authority within the NHS and is responsible for the provision of blood components and a range of associated laboratory and patient therapeutic services to hospitals in England and Wales. Therapeutic Apheresis Services (TAS) provide lifesaving and life-enhancing therapies to adults and children from across a range of clinical specialties. Patients receive treatment either at their hospital bedside or where clinically appropriate as an outpatient in an NHS Blood and Transplant (NHSBT) unit. NHSBT provides regional access to apheresis services…
This is a public summary of a procurement notice. Dates and status reflect the notice held by BidScout; check the full notice before bidding.
Full tender details have a three-minute guest preview for open opportunities. AI insights require registration.
Register for full access